Published in Infection on December 01, 2006
Citrobacter infections in a general hospital: characteristics and outcomes. Eur J Clin Microbiol Infect Dis (2008) 1.61
Whole-genome sequencing and identification of Morganella morganii KT pathogenicity-related genes. BMC Genomics (2012) 0.97
Clinical manifestations and prognostic factors of Morganella morganii bacteremia. Eur J Clin Microbiol Infect Dis (2014) 0.92
A Case of Giant Hepatic Hydatid Cyst Infected with Morganella morganii and the Literature Review. Case Rep Gastrointest Med (2012) 0.90
Persistent infection with metallo-beta-lactamase and extended spectrum β-lactamase producer Morganella morganii in a patient with urinary tract infection after kidney transplantation. J Nat Sci Biol Med (2016) 0.83
Structural characterization and MHCII-dependent immunological properties of the zwitterionic O-chain antigen of Morganella morganii. Glycobiology (2011) 0.83
Trends of isolation of intrinsically resistant to colistin Enterobacteriaceae and association with colistin use in a tertiary hospital. Eur J Clin Microbiol Infect Dis (2014) 0.81
Draft Whole-Genome Sequence of Morganella morganii Serotype O:1ab. Genome Announc (2015) 0.81
Morganella morganii Pericarditis in a Patient with Multiple Myeloma. Case Rep Hematol (2013) 0.80
A metaproteomics approach to elucidate host and pathogen protein expression during catheter-associated urinary tract infections (CAUTIs). Mol Cell Proteomics (2015) 0.79
Giant Iliopsoas Abscess Caused by Morganella Morganii. Am J Case Rep (2017) 0.75
Morganella morganii causing abscess over the anterior chest wall- a case report. J Clin Diagn Res (2014) 0.75
Draft Genomic Analysis of an Avian Multidrug Resistant Morganella morganii Isolate Carrying qnrD1. Front Microbiol (2016) 0.75
Infected cephalohematomas and underlying osteomyelitis: a case-based review. Childs Nerv Syst (2016) 0.75
Resistance to ticarcillin-potassium clavulanate among clinical isolates of the family Enterobacteriaceae: role of PSE-1 beta-lactamase and high levels of TEM-1 and SHV-1 and problems with false susceptibility in disk diffusion tests. Antimicrob Agents Chemother (1988) 3.92
A multicenter phase III trial comparing irinotecan-gemcitabine (IG) with gemcitabine (G) monotherapy as first-line treatment in patients with locally advanced or metastatic pancreatic cancer. Br J Cancer (2006) 2.57
Bibliometric analysis of global trends for research productivity in microbiology. Eur J Clin Microbiol Infect Dis (2005) 1.65
Recent experience with Pseudomonas aeruginosa bacteremia in patients with cancer: Retrospective analysis of 245 episodes. Arch Intern Med (2000) 1.62
Citrobacter infections in a general hospital: characteristics and outcomes. Eur J Clin Microbiol Infect Dis (2008) 1.61
Pseudomonas aeruginosa urinary tract infection in children: risk factors and outcomes. J Urol (2011) 1.49
Clinical presentation of zygomycosis. Clin Microbiol Infect (2009) 1.38
The epidemiology of onychomycoses in Crete, Greece, between 1992 and 2001. J Eur Acad Dermatol Venereol (2006) 1.38
Inhaled colistin as adjunctive therapy to intravenous colistin for the treatment of microbiologically documented ventilator-associated pneumonia: a comparative cohort study. Clin Microbiol Infect (2009) 1.29
Role of catheter colonization and infrequent hematogenous seeding in catheter-related infections. Eur J Clin Microbiol Infect Dis (1995) 1.24
Infection and immunity in chronic lymphocytic leukemia. Mayo Clin Proc (2000) 1.23
Newer macrolides as empiric treatment for acute Q fever infection. Antimicrob Agents Chemother (2001) 1.20
Voriconazole-associated zygomycosis: a significant consequence of evolving antifungal prophylaxis and immunosuppression practices? Clin Microbiol Infect (2009) 1.19
Comparison of the efficacy of polyenes and triazoles against hematogenous Candida krusei infection in neutropenic mice. J Infect Dis (1993) 1.19
Prospective evaluation of effects of broad-spectrum antibiotics on gastrointestinal yeast colonization of humans. Antimicrob Agents Chemother (1993) 1.18
Prospective study of the impact of broad-spectrum antibiotics on the yeast flora of the human gut. Eur J Clin Microbiol Infect Dis (1994) 1.13
Effectiveness and nephrotoxicity of intravenous colistin for treatment of patients with infections due to polymyxin-only-susceptible (POS) gram-negative bacteria. Eur J Clin Microbiol Infect Dis (2006) 1.13
Evaluation of the GenoType MTBC assay for differentiating 120 clinical Mycobacterium tuberculosis complex isolates. Eur J Clin Microbiol Infect Dis (2007) 1.13
Surgical wound infection caused by Rahnella aquatilis. J Clin Microbiol (1994) 1.11
Triplet combination with irinotecan plus oxaliplatin plus continuous-infusion fluorouracil and leucovorin as first-line treatment in metastatic colorectal cancer: a multicenter phase II trial. J Clin Oncol (2002) 1.09
A 5-year study of the bacterial pathogens associated with acute diarrhoea on the island of Crete, Greece, and their resistance to antibiotics. Eur J Epidemiol (2003) 1.07
First case of resistance to tigecycline by Klebsiella pneumoniae in a European University Hospital. Indian J Med Microbiol (2011) 1.03
Brachyspira (Serpulina) pilosicoli spirochetemia in an immunocompromised patient. Infection (2002) 1.02
Transient fungemia due to Rhodotorula rubra in a cancer patient: case report and review of the literature. Infection (2001) 1.00
The impact of norfloxacin, ciprofloxacin and ofloxacin on human gut colonization by Candida albicans. Scand J Infect Dis (2001) 0.98
Systemic mycoses in the immunocompromised host: an update in antifungal therapy. J Hosp Infect (2003) 0.98
An outbreak of diarrhoeal disease attributed to Shigella sonnei. Epidemiol Infect (1994) 0.98
Candidemia in immunocompromised and immunocompetent critically ill patients: a prospective comparative study. Eur J Clin Microbiol Infect Dis (2007) 0.97
Gram-negative bacteremia in non-neutropenic patients: a 3-year review. Infection (1998) 0.97
Infections by pandrug-resistant gram-negative bacteria: clinical profile, therapeutic management, and outcome in a series of 21 patients. Eur J Clin Microbiol Infect Dis (2010) 0.96
First case report of Streptococcus suis septicaemia and meningitis from Greece. Eur J Neurol (2005) 0.96
In vitro susceptibility of Citrobacter species to various antimicrobial agents. Antimicrob Agents Chemother (1987) 0.96
Resistance of Mycobacterium tuberculosis isolates in different populations in Greece during 1993-2002. Int J Tuberc Lung Dis (2006) 0.95
Salvage chemotherapy in anthracycline-pretreated metastatic breast cancer patients with docetaxel and gemcitabine: a multicenter phase II trial. Greek Breast Cancer Cooperative Group. Ann Oncol (1999) 0.95
Resistance status and evolution trends of Klebsiella pneumoniae isolates in a university hospital in Greece: ineffectiveness of carbapenems and increasing resistance to colistin. Chemotherapy (2010) 0.94
Synergy of fosfomycin with carbapenems, colistin, netilmicin, and tigecycline against multidrug-resistant Klebsiella pneumoniae, Escherichia coli, and Pseudomonas aeruginosa clinical isolates. Eur J Clin Microbiol Infect Dis (2011) 0.93
Infections in traumatic brain injury patients. Clin Microbiol Infect (2011) 0.91
Candidaemia: incidence, risk factors, characteristics and outcomes in immunocompetent critically ill patients. Clin Microbiol Infect (2009) 0.91
A case of Opisthorchis felineus infestation in a pilot from Greece. Infection (2003) 0.90
Environmental surveillance of filamentous fungi in three tertiary care hospitals in Greece. J Hosp Infect (2002) 0.90
Molecular epidemiology and risk factors for colonization by vancomycin-resistant Enterococcus in patients with hematologic malignancies. Infect Control Hosp Epidemiol (2011) 0.90
Airborne hydrogen peroxide for disinfection of the hospital environment and infection control: a systematic review. J Hosp Infect (2011) 0.90
Phase I study of paclitaxel (taxol) and pegylated liposomal doxorubicin (caelyx) administered every 2 weeks in patients with advanced solid tumors. Oncology (2002) 0.89
Infections due to Cunninghamella bertholletiae in patients with cancer: report of three cases and review. Clin Infect Dis (1994) 0.89
Serotypes and susceptibilities of paediatric clinical isolates of Streptococcus pneumoniae in Crete, Greece, before and after the heptavalent pneumococcal conjugate vaccine. Eur J Clin Microbiol Infect Dis (2010) 0.88
Infant colonization by Staphylococcus aureus: role of maternal carriage. Eur J Clin Microbiol Infect Dis (2011) 0.87
A dose-escalation and pharmacokinetic study of gemcitabine and oxaliplatin in patients with advanced solid tumors. Ann Oncol (2003) 0.87
Post-surgical meningitis due to multiresistant Acinetobacter baumannii. Effective treatment with intravenous and/or intraventricular colistin and therapeutic dilemmas. Med Mal Infect (2007) 0.86
First-line treatment of advanced nonsmall cell lung carcinoma with docetaxel and vinorelbine. Cancer (1998) 0.86
Local complications of erysipelas: a study of associated risk factors. Clin Exp Dermatol (2010) 0.86
Effect of norfloxacin, trimethoprim-sulfamethoxazole and nitrofurantoin on fecal flora of women with recurrent urinary tract infections. J Chemother (1997) 0.86
Treatment of non-small-cell lung cancer with prolonged oral etoposide. Am J Clin Oncol (1998) 0.86
Successful conservative treatment of neutropenic enterocolitis complicating taxane-based chemotherapy: a report of five cases. Am J Clin Oncol (2000) 0.86
Bloodstream infections in patients with solid tumors: associated factors, microbial spectrum and outcome. Infection (2004) 0.85
Phase I study of weekly paclitaxel and liposomal doxorubicin in patients with advanced solid tumours. Eur J Cancer (2002) 0.84
Spontaneous spondylodiscitis caused by Klebsiella pneumoniae. Infection (2000) 0.83
Cutaneous alternariosis revealing acute myeloid leukaemia in an adult patient. Mycoses (2004) 0.83
Long-term survival of a patient with a neurofibromatosis Type 1 associated retroperitoneal malignant triton tumor after multi-modality treatment. Clin Neuropathol (2011) 0.83
Effects of cefepime, cefixime and ceftibuten on murine gut colonization by Candida albicans. Chemotherapy (1998) 0.82
Bacterial pathogens associated with diarrhoea on the island of Crete. Eur J Epidemiol (1997) 0.82
Oxaliplatin in combination with infusional 5-fluorouracil and leucovorin every 2 weeks as first-line treatment in patients with advanced colorectal cancer: a phase II study. Oncology (2001) 0.82
Multi-drug-resistant gram-negative bacterial infection in surgical patients hospitalized in the ICU: a cohort study. Eur J Clin Microbiol Infect Dis (2011) 0.82
A dose escalation study of weekly docetaxel in patients with advanced solid tumors. Cancer Chemother Pharmacol (2000) 0.81
Prospective evaluation of the impact of amoxicillin, clarithromycin and their combination on human gastrointestinal colonization by Candida species. Chemotherapy (2001) 0.81
Multicentric Castleman's disease: prolonged remission with anti CD-20 monoclonal antibody in an HIV-infected patient. AIDS (2004) 0.81
Trends of isolation of intrinsically resistant to colistin Enterobacteriaceae and association with colistin use in a tertiary hospital. Eur J Clin Microbiol Infect Dis (2014) 0.81
Invasive Salmonella virchow infection in childhood. Scand J Infect Dis (2001) 0.81
Second-line treatment with irinotecan plus cisplatin vs cisplatin of patients with advanced non-small-cell lung cancer pretreated with taxanes and gemcitabine: a multicenter randomised phase II study. Br J Cancer (2005) 0.81
Effects of doxycycline, metronidazole and their combination on Candida species colonization of the human oropharynx, intestinal lumen and vagina. J Chemother (2003) 0.81
Proteinuria and favourable clinical response in a patient receiving paclitaxel + bevacizumab for metastatic breast cancer. Ann Oncol (2010) 0.81
Serratia infections in a general hospital: characteristics and outcomes. Eur J Clin Microbiol Infect Dis (2011) 0.81
Psychometric properties of the QLQ-C30 (version 3.0) in a sample of ambulatory Cretan cancer patients. Eur J Cancer Care (Engl) (2009) 0.80
Docetaxel in combination with dacarbazine in patients with advanced melanoma. Oncology (2002) 0.80
Native valve Aspergillus endocarditis in two patients with aplastic anaemia. Scand J Infect Dis (2006) 0.80
Common symptoms--different diseases: coexistence of neurosyphilis and non-Hodgkin's lymphoma. Infection (2002) 0.80
Comparison of docetaxel/cisplatin to docetaxel/gemcitabine as first-line treatment of advanced non-small cell lung cancer: early results of a randomized trial. Lung Cancer (2001) 0.80
Serotype distribution and antimicrobial resistance of adult Streptococcus pneumoniae clinical isolates over the period 2001-2008 in Crete, Greece. Chemotherapy (2010) 0.79
Salvage chemotherapy with paclitaxel, vinorelbine, and cisplatin (PVC) in anthracycline-resistant advanced breast cancer. Am J Clin Oncol (1998) 0.79
Systematic review: fluoroquinolones for the treatment of intra-abdominal surgical infections. Aliment Pharmacol Ther (2007) 0.79
Ceftriaxone and dexamethasone affecting yeast gut flora in experimental mice. J Chemother (1999) 0.79
Effects of cyclophosphamide and ceftriaxone on gastrointestinal colonization of mice by Candida albicans. Antimicrob Agents Chemother (1996) 0.79
Characteristics, risk factors and outcomes of adult cancer patients with extensively drug-resistant Pseudomonas aeruginosa infections. Infection (2014) 0.78
Infantile fibromatosis of the mandible: a case report. Dentomaxillofac Radiol (2008) 0.78
Efficacy of amikacin, ofloxacin, pefloxacin, ciprofloxacin, enoxacin and fleroxacin in experimental left-sided Pseudomonas aeruginosa endocarditis. Chemotherapy (2000) 0.78
Effect of a policy for restriction of selected classes of antibiotics on antimicrobial drug cost and resistance. J Chemother (2007) 0.78
Phase I study of the gemcitabine/oxaliplatin combination in patients with advanced solid tumors: a preliminary report. Semin Oncol (2000) 0.78